<VariationArchive VariationID="1172" VariationName="NC_000008.11:g.(142876886_142877022)_(142914909_142915045)dup" VariationType="Duplication" Accession="VCV000001172" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-01" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="16211" VariationID="1172">
      <GeneList>
        <Gene Symbol="CYP11B1" FullName="cytochrome P450 family 11 subfamily B member 1" GeneID="1584" HGNC_ID="HGNC:2591" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>8q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="142872357" stop="142879825" display_start="142872357" display_stop="142879825" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="143953772" stop="143961235" display_start="143953772" display_stop="143961235" Strand="-" />
          </Location>
          <OMIM>610613</OMIM>
        </Gene>
        <Gene Symbol="CYP11B2" FullName="cytochrome P450 family 11 subfamily B member 2" GeneID="1585" HGNC_ID="HGNC:2592" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>8q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="142910559" stop="142917843" display_start="142910559" display_stop="142917843" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="143991974" stop="143999258" display_start="143991974" display_stop="143999258" Strand="-" />
          </Location>
          <OMIM>124080</OMIM>
        </Gene>
        <Gene Symbol="LOC106799833" FullName="CYP11B1 recombination region" GeneID="106799833" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>8q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="142874234" stop="142879022" display_start="142874234" display_stop="142879022" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC106799834" FullName="CYP11B2 recombination region" GeneID="106799834" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>8q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="142903458" stop="142918174" display_start="142903458" display_stop="142918174" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC110673972" FullName="CYP11B1 promoter" GeneID="110673972" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>8q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="142879723" stop="142881144" display_start="142879723" display_stop="142881144" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NC_000008.11:g.(142876886_142877022)_(142914909_142915045)dup</Name>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>8q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" outerStart="142876886" innerStart="142877022" innerStop="142914909" outerStop="142915045" display_start="142876886" display_stop="142915045" variantLength="38160" />
      </Location>
      <OtherNameList>
        <Name>CYP11B1, CYP11B1/CYP11B2 ANTI-LEPORE-LIKE CHIMERA</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.(142876886_142877022)_(142914909_142915045)dup" Assembly="GRCh38">
            <Expression>NC_000008.11:g.(142876886_142877022)_(142914909_142915045)dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="610613.0002" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an indeterminate HGVS expression for OMIM allelic variant 610613.0002 from the description in Figure 3 of the paper by Lifton et al., 1992 (PubMed 1731223) that the unequal crossing over occurred in intron 3 of both genes.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000008.11:g.(142876886_142877022)_(142914909_142915045)dup AND Glucocorticoid-remediable aldosteronism" Accession="RCV000001231" Version="2">
        <ClassifiedConditionList TraitSetID="313">
          <ClassifiedCondition DB="MedGen" ID="C3838731">Glucocorticoid-remediable aldosteronism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2004-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2004-09-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15324322</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1731223</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="313" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5196" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Glucocorticoid-remediable aldosteronism</ElementValue>
                <XRef ID="Glucocorticoid-remediable+aldosteronism/8476" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007080" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ACTH-DEPENDENT HYPERALDOSTERONISM SYNDROME</ElementValue>
                <XRef Type="MIM" ID="103900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALDOSTERONISM, SENSITIVE TO DEXAMETHASONE</ElementValue>
                <XRef Type="MIM" ID="103900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FH I</ElementValue>
                <XRef Type="MIM" ID="103900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLUCOCORTICOID-SUPPRESSIBLE HYPERALDOSTERONISM</ElementValue>
                <XRef Type="MIM" ID="103900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperaldosteronism, familial, type I</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GRA</ElementValue>
                <XRef Type="MIM" ID="103900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GSH</ElementValue>
                <XRef Type="MIM" ID="103900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HALD1</ElementValue>
                <XRef Type="MIM" ID="103900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2790" />
                <XRef ID="2790" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="403" DB="Orphanet" />
              <XRef ID="C3838731" DB="MedGen" />
              <XRef ID="MONDO:0007080" DB="MONDO" />
              <XRef Type="MIM" ID="103900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="21381" SubmissionDate="2009-07-01" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="610613.0002_GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM" title="CYP11B1, CYP11B1/CYP11B2 ANTI-LEPORE-LIKE CHIMERA_GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM" />
        <ClinVarAccession Accession="SCV000021381" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a family with glucocorticoid-remediable aldosteronism (103900), clinically characterized by hypertension, variable hyperaldosteronism, and increased levels of the abnormal adrenal steroids 18-oxocortisol and 18-hydroxycortisol, Lifton et al. (1992) identified a chimeric gene in which the 5-prime regulatory sequences of the CYP11B1 gene were fused to the coding region of the CYP11B2 gene (124080), which encodes aldosterone synthase, resulting in ectopic expression of aldosterone synthase in the zona fasciculata. The 2 genes were closely linked in a head-to-tail orientation with the CYP11B2 gene 5-prime to the CYP11B1 gene. The chimeric gene is of the anti-Lepore type, as in hemoglobin Miyada (141900.0179). Polymorphic markers of the CYP11B1 and CYP11B2 genes showed complete linkage (maximum lod score = 3.63), indicating that these are contiguous genes. Lifton et al. (1992) referred to the change as a neomorphic mutation. They suggested that aberrations of this type leading to hypertension inherited as an autosomal dominant trait may be more frequent than previously realized.</Attribute>
              <Citation>
                <ID Source="PubMed">1731223</ID>
              </Citation>
              <XRef DB="OMIM" ID="103900" Type="MIM" />
              <XRef DB="OMIM" ID="124080" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">See 610613.0014 and Ezquieta and Luzuriaga (2004) for a description of a deletion hybrid that appears to be the reciprocal recombination product to this duplication hybrid.</Attribute>
              <Citation>
                <ID Source="PubMed">15324322</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP11B1" />
          </GeneList>
          <Name>CYP11B1, CYP11B1/CYP11B2 ANTI-LEPORE-LIKE CHIMERA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">CYP11B1/CYP11B2 ANTI-LEPORE-LIKE CHIMERA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="610613.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="21381" TraitType="Disease" MappingType="Name" MappingValue="GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM" MappingRef="Preferred">
        <MedGen CUI="C3838731" Name="Glucocorticoid-remediable aldosteronism" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

